These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6861042)

  • 1. Radioimmunotechnology for cancer diagnosis and treatment.
    Holt S; Longenecker BM; Noujaim AA
    Can Med Assoc J; 1983 Jul; 129(1):18-9, 41. PubMed ID: 6861042
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st immunologic attempts in the treatment of human malignant tumors].
    Mannelli MA
    Minerva Med; 1977 Apr; 68(19):1301-4. PubMed ID: 854230
    [No Abstract]   [Full Text] [Related]  

  • 3. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
    DelVillano BC; Zurawski VR
    Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
    [No Abstract]   [Full Text] [Related]  

  • 4. Bi-specific antibody therapy for the treatment of cancer.
    Withoff S; Helfrich W; de Leij LF; Molema G
    Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific active immunotherapy of cancer].
    Valladares Y
    An R Acad Nac Med (Madr); 1982; 99(1):109-46. PubMed ID: 6181704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cancer immunotherapy. A future therapeutical choice?].
    Bertolaccini L; Olivero G
    Minerva Chir; 2001 Apr; 56(2):183-91. PubMed ID: 11353352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third international Dresden symposium on immunotherapy of cancer.
    Schmitz M; Bornhauser M; Ockert D; Rieber EP
    Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic principles of the immune response and the immunologic inhibition of tumors.
    Vorlaender KO
    Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemistry and clinical evaluation of cancer-associated carbohydrate antigens: an approach to the diagnosis using monoclonal antibody cocktails].
    Kannagi R
    Rinsho Byori; 1986 Nov; 34(11):1247-64. PubMed ID: 3820695
    [No Abstract]   [Full Text] [Related]  

  • 15. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of gene technology and immunoassay in the diagnosis of cancer].
    Kawai T
    Rinsho Byori; 1987 Nov; 35(11):1213-5. PubMed ID: 3444056
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospects for improving antibody therapy for carcinoma].
    Liu XY
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1145-6. PubMed ID: 15387972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.